Forbion Capital Partners
Overview
Forbion is a leading global venture capital firm with deep expertise in Europe and offices in Naarden, The Netherlands, Munich, Germany and Boston, USA. Forbion invests in innovative biotech companies, managing approximately €5 billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development. In addition, Forbion leverages its biotech expertise beyond human health to address 'planetary health' challenges through its BioEconomy fund strategy, which invests in companies developing sustainable solutions in food, agriculture, materials, and environmental technologies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CellCentric | May 2025 | Series C | Lead |
| Achilles Therapeutics | Nov 2020 | Series C | - |
| Beacon Therapeutics | Jul 2024 | Series B | Lead |
| Anaveon | Dec 2021 | Series B | Lead |
| Altesa BioSciences | Feb 2026 | Series B | Lead |
For institutional investors. Book with your work email.
Key People
Geert-Jan Mulder
Managing Partner
John Montana
Operating Partner
Thomas Gundelund Rasmussen
Operating Partner
Jens Wendland
Venture Partner
Holger Reithinger
Partner
Joy Faucher
Partner
Mathias Vinther
Principal
Joseph Iwasyk
Venture Capital Fellow
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Forbion Capital Partners based?
Forbion Capital Partners is headquartered in Naarden, North Holland, Netherlands.
When was Forbion Capital Partners founded?
Forbion Capital Partners was founded in 2000.
How many portfolio companies does Forbion Capital Partners have?
Forbion Capital Partners has 19 portfolio companies in Caplight's dataset.
What are some companies in Forbion Capital Partners's portfolio?
Portfolio companies visible on Caplight include CellCentric, Achilles Therapeutics, Beacon Therapeutics, Anaveon, Altesa BioSciences.
What was Forbion Capital Partners's most recent investment shown here?
Forbion Capital Partners's most recent investment in this portfolio sample was in Altesa BioSciences in 2026.
What sectors does Forbion Capital Partners focus on?
Forbion Capital Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does Forbion Capital Partners focus on?
Forbion Capital Partners typically invests at the Mid stage.
What is Forbion Capital Partners's AUM?
Forbion Capital Partners's assets under management are estimated between $1.0B and $10.0B.